VERALOX THERAPEUTICS
Live / Registered — Registered (as of 28 Oct 2025)
What this means for you
Registered since 28 Oct 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97419155
- Registration number
- 8005322
- Mark type
- Stylized text
- Filed
- 19 May 2022
- Published for opposition
- 18 Apr 2023
- Registered
- 28 Oct 2025
- Attorney of record
- Susan Piascik Christoff
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products, namely, chemical and small molecule preparations for use in treatment of blood disorders; pharmaceutical formulations for treatment of blood disorders
Owner
- Veralox Therapeutics Inc., Frederick, MD, US
- Veralox Therapeutics Inc., Frederick, MD, US
- Veralox Therapeutics Inc., Frederick, MD, US
Prior registrations
Prosecution history
- 28 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Oct 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Jun 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 30 Jun 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 09 Apr 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 Apr 2025 — NON-FINAL ACTION E-MAILED
- 09 Apr 2025 — SU - NON-FINAL ACTION - WRITTEN
- 21 Feb 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Dec 2024 — USE AMENDMENT FILED
- 21 Feb 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Dec 2024 — TEAS STATEMENT OF USE RECEIVED
- 10 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Dec 2024 — SOU EXTENSION 3 GRANTED